User profiles for Cecilia Acuti Martellucci

Cecilia Martellucci

University of Ferrara
Verified email at unife.it
Cited by 1073

Risk of reinfection and disease after SARS‐CoV‐2 primary infection: meta‐analysis

ME Flacco, C Acuti Martellucci… - European journal of …, 2022 - Wiley Online Library
Introduction A precise estimate of the frequency and severity of SARS‐CoV‐2 reinfections
would be critical to optimize restriction and vaccination policies for the hundreds of millions …

SARS-CoV-2 pandemic: An overview

CA Martellucci, ME Flacco, R Cappadona… - Advances in biological …, 2020 - Elsevier
By the end of May 2020, SARS-CoV-2 pandemic caused more than 350,000 deaths
worldwide. In the first months, there have been uncertainties on almost any area: infection …

Adverse intrapartum outcome in pregnancies complicated by small for gestational age and late fetal growth restriction undergoing induction of labor with Dinoprostone …

…, A D'Amico, ME Flacco, CA Martellucci… - European Journal of …, 2020 - Elsevier
Objective To investigate the outcome of pregnancies with small baby, including both small for
gestational age (SGA) and late fetal growth restriction (FGR) fetuses, undergoing induction …

[HTML][HTML] Risk of SARS-CoV-2 reinfection 18 months after primary infection: population-level observational study

ME Flacco, G Soldato, C Acuti Martellucci… - Frontiers in Public …, 2022 - frontiersin.org
Current data suggest that SARS-CoV-2 reinfections are rare. Uncertainties remain, however,
on the duration of the natural immunity, its protection against Omicron variant, and on the …

Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis

ME Flacco, CA Martellucci, F Bravi, G Parruti… - Heart, 2020 - heart.bmj.com
Objective It has been hypothesised that the use of ACE inhibitors and angiotensin receptor
blockers (ARBs) might either increase or reduce the risk of severe or lethal COVID-19. The …

[HTML][HTML] Predictors of severe or lethal COVID-19, including Angiotensin Converting Enzyme inhibitors and Angiotensin II Receptor Blockers, in a sample of infected …

…, CA Volta, G Cosenza, A De Togni, C Acuti Martellucci… - PloS one, 2020 - journals.plos.org
Aims This retrospective case-control study was aimed at identifying potential independent
predictors of severe/lethal COVID-19, including the treatment with Angiotensin-Converting …

[HTML][HTML] COVID-19 vaccines reduce the risk of SARS-CoV-2 reinfection and hospitalization: Meta-analysis

ME Flacco, C Acuti Martellucci, V Baccolini… - Frontiers in …, 2022 - frontiersin.org
The addictive protection against SARS-CoV-2 reinfection conferred by vaccination, as
compared to natural immunity alone, remains to be quantified. We carried out a meta-analysis to …

[HTML][HTML] Interim estimates of COVID-19 vaccine effectiveness in a mass vaccination setting: data from an Italian Province

ME Flacco, G Soldato, C Acuti Martellucci, R Carota… - Vaccines, 2021 - mdpi.com
This retrospective cohort study compared the rates of virologically-confirmed SARS-CoV-2
infections, symptomatic or lethal COVID-19 among the residents of the Italian province of …

[HTML][HTML] Effectiveness of COVID-19 Vaccines in the General Population of an Italian Region before and during the Omicron Wave

C Acuti Martellucci, ME Flacco, G Soldato, G Di Martino… - Vaccines, 2022 - mdpi.com
We performed a cohort analysis of the entire population of Abruzzo, Italy, to evaluate the real-world
effectiveness of SARS-CoV-2 vaccines against infection, COVID-19 hospitalization or …

[HTML][HTML] Changes in the spatial distribution of COVID-19 incidence in Italy using GIS-based maps

CA Martellucci, R Sah, AA Rabaan, K Dhama… - Annals of Clinical …, 2020 - Springer
… Although the epidemic of COVID-19 caused by the severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) started in Italy on January 31, 2020, no reports on the use of GIS-…